A Japanese Encephalitis Vaccine From India Induces Durable and Cross-protective Immunity Against Temporally and Spatially Wide-ranging Global Field Strains (Q41559489)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 January 2015

Language	Label	Description	Also known as
English	A Japanese Encephalitis Vaccine From India Induces Durable and Cross-protective Immunity Against Temporally and Spatially Wide-ranging Global Field Strains	scientific article published on 18 January 2015

Statements

scholarly article

1 reference

Europe PubMed Central

3 October 2017

A Japanese Encephalitis Vaccine From India Induces Durable and Cross-protective Immunity Against Temporally and Spatially Wide-ranging Global Field Strains (English)

1 reference

Europe PubMed Central

3 October 2017

Japanese encephalitis virus

0 references

0 references

Japanese encephalitis

1 reference

based on heuristic

inferred from title

Japanese encephalitis vaccine

1 reference

based on heuristic

inferred from title

object named as

Nagendra R Hegde

13

0 references

author name string

Anit Singh

1

1 reference

Europe PubMed Central

3 October 2017

Monjori Mitra

2

1 reference

Europe PubMed Central

3 October 2017

Gadey Sampath

3

1 reference

Europe PubMed Central

3 October 2017

P Venugopal

4

1 reference

Europe PubMed Central

3 October 2017

J Venkateswara Rao

5

1 reference

Europe PubMed Central

3 October 2017

B Krishnamurthy

6

1 reference

Europe PubMed Central

3 October 2017

Mukesh Kumar Gupta

7

1 reference

Europe PubMed Central

3 October 2017

S Sri Krishna

8

1 reference

Europe PubMed Central

3 October 2017

B Sudhakar

9

1 reference

Europe PubMed Central

3 October 2017

N Bhuvaneswara Rao

10

1 reference

Europe PubMed Central

3 October 2017

Yashpal Kaushik

11

1 reference

Europe PubMed Central

3 October 2017

K Gopinathan

12

1 reference

Europe PubMed Central

3 October 2017

Milind M Gore

14

1 reference

Europe PubMed Central

3 October 2017

V Krishna Mohan

15

1 reference

Europe PubMed Central

3 October 2017

Krishna M Ella

16

1 reference

Europe PubMed Central

3 October 2017

language of work or name

0 references

publication date

18 January 2015

1 reference

Europe PubMed Central

3 October 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

3 October 2017

212

1 reference

Europe PubMed Central

3 October 2017

715-725

1 reference

Europe PubMed Central

3 October 2017

5

1 reference

Europe PubMed Central

3 October 2017

Estimated global incidence of Japanese encephalitis: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Recent advances in Japanese encephalitis.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

New Japanese encephalitis vaccines: alternatives to production in mouse brain

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Japanese encephalitis vaccine: need of the hour in endemic states of India

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Japanese Encephalitis Outbreak, India, 2005.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Japanese encephalitis in India: an overview

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Development and preclinical testing of HNVAC, a cell culture-based H1N1 pandemic influenza vaccine from India.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Establishment of an analyzing method for a Japanese encephalitis virus neutralization test in Vero cells

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Japanese encephalitis: new options for active immunization

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

A chimeric live attenuated vaccine against Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Non-clinical and phase I clinical trials of a Vero cell-derived inactivated Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Partially neutralizing potency against emerging genotype I virus among children received formalin-inactivated Japanese encephalitis virus vaccine

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

A single dose of vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from south-east Asia and India

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: a two-year follow-up study

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Dynamics of the emergence and establishment of a newly dominant genotype of Japanese encephalitis virus throughout Asia

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Comparison of genotypes I and III in Japanese encephalitis virus reveals distinct differences in their genetic and host diversity

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Genotype v Japanese encephalitis virus is emerging

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Emergence of Japanese encephalitis virus genotype V in the Republic of Korea.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Immunogenicity and safety of IXIARO (IC51) in a Phase II study in healthy Indian children between 1 and 3 years of age.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years, India, 2013 and updates on immunization

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Low coverage and acceptable effectiveness of single dose of Japanese encephalitis vaccine, Gorakhpur division, Uttar Pradesh, India, 2013.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Changes in acute encephalitis syndrome incidence after introduction of Japanese encephalitis vaccine in a region of India.

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Post-marketing surveillance of live-attenuated Japanese encephalitis vaccine safety in China

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Incidence of Japanese encephalitis among acute encephalitis syndrome cases in West Bengal, India

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV023

21 January 2018

Identifiers

10.1093/INFDIS/JIV023

1 reference

Europe PubMed Central

3 October 2017

1 reference

Europe PubMed Central

3 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41559489&oldid=1924346895"